oxazoles has been researched along with Amyloid Deposits in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qi, JS; Wang, CF; Wang, ZJ; Wu, MN; Xiao, Y; Yang, W; Zhang, J; Zhang, XM; Zhao, F; Zhou, F | 1 |
Barrow, JC; Connolly, B; Cook, JJ; Fan, H; Gammage, L; Hargreaves, RJ; Harrison, ST; Hostetler, ED; Miller, P; Mulhearn, J; O'Malley, S; Sanabria-Bohórquez, S; Sur, C; Williams, DL; Wolkenberg, SE; Zeng, Z | 1 |
2 other study(ies) available for oxazoles and Amyloid Deposits
Article | Year |
---|---|
Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Hippocampus; Macrocyclic Compounds; Male; Maze Learning; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Nootropic Agents; Oxazoles; Plaque, Amyloid | 2019 |
[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey.
Topics: Alzheimer Disease; Animals; Autoradiography; Brain; Fluorine Radioisotopes; Humans; Inhibitory Concentration 50; Macaca mulatta; Oxazoles; Plaque, Amyloid; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Tissue Distribution | 2011 |